GV 2015 GP, L.L.C. 3
3 · Spero Therapeutics, Inc. · Filed Nov 1, 2017
Insider Transaction Report
Form 3
GV 2015 GP, L.L.C.
10% Owner
Holdings
- (indirect: By GV 2015, L.P.)
Series C Preferred Stock
→ Common Stock (1,112,473 underlying)
Footnotes (3)
- [F1]The shares of Series C preferred stock beneficially owned by the Reporting Persons are convertible into the number of shares of common stock shown in Column 3 at any time at the holder's election and automatically convert immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
- [F2]Share numbers give effect to the 1-for-6.0774 reverse stock split of the Issuer's common stock effected on October 20, 2017.
- [F3]The shares are directly held by GV 2015, L.P. GV 2015 GP, L.L.C., the general partner of GV 2015, L.P., Alphabet Holdings LLC, the sole member of GV 2015 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote and dispose of these shares. Each of GV 2015 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.